MiRNA expression profiles of oral squamous cell carcinomas

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1511-1518

  Gombos, Katalin ^a   Horváth, Róbert ^a   Szele, Eszter ^a   Juhász, Krisztina ^a   Gocze, Katalin ^a   Somlai, Károly ^b   Pajkos, Gábor ^c   Ember, István ^a   Olasz, Lajos ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Department of Dentistry and Maxillofacial Surgery   (Hungary)

^c BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Genomics; MiRNA expression; Oral cancer; Squamous cell carcinoma

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 155; MICRORNA 191; MICRORNA 21; MICRORNA 221; MICRORNA 222; RNA 5S; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIMENTAL DESIGN; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUTH CARCINOGENESIS; MOUTH SQUAMOUS CELL CARCINOMA; POLYADENYLATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84876759018     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. www.http://globocan.iarc.fr/factsheet.asp, last accessed 09.01. 2013.
2. Argiris A, Karamouzis MV, Raben D and Ferris RL: Head and neck cancer. Lancet 371: 1695-1709, 2008. (Pubitemid 351671886)
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics Cancer J Clin 58: 71-96, 2008.
4. Stewart BW, Greim H, Shuker D and Kauppinen T: Defence of IARC monographs. Lancet 361: 13003-13006, 2003.
5. Wise Draper TM, Draper D, Gutkind JS, Molinolo AA, Wikendheiser-Brocamp KA and Wells SI: Future directions and treatment strategies for head and neck squamous cell carcinomas. Transl Res 160(3): 167-77, 2012
6. Mydlarz WK, Hennessey PT and Califano JA: Advances and perspectives in the molecular diagnosis of head and neck cancer. Expert Opin Med Diagn 4: 53-65, 2010.
7. Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, De Rosa G and Staibano S: Epigenetic dysregulation in oral cancer. Int J Mol Sci 13(2): 2331-2353, 2012.
8. Saintigny P, Zhang L, Fan YH, El-Naggar AK, Papadimitrakopoulou VA, Feng L, Lee JJ, Kim ES, Hong WK and Mao L: Gene expression profiling predicts the development of oral cancer. Cancer Prevent Res 4(2): 218-229, 2011.
9. Liu W, Shi LJ, Wu LL, Feng JQ, Yang XX, Li JJ, Zhou ZT and Zhang CP: Oral cancer development in patients with leukoplakia-clinicopathological factors affecting outcome. PLoS One 7(4): e34773, 2012.
10. Mao L, Lee JS, Fan YH, Ro J Y, Batsakis JG, Lippman S, Hittelman W and Hong WK: Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2(6): 682-685, 1996. (Pubitemid 26191956)
11. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK and Lippman SM: Predicting cancer development in oral leukoplakia: Ten years of translational research. Clin Cancer Res 6(5): 1702-1710, 2000. (Pubitemid 30305062)
12. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM and Mao L: Podoplanin: A novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol 26(3): 354-360, 2008. (Pubitemid 351171684)
13. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim ES, Hong WK, Lippman SM and Mao L: DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res 15(19): 6284-6291, 2009.
14. Mehrotra R and Gupta DK: Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol 3(33): 1-8, 2011.
15. Woolgar JA and Triantafyllou A: Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol 45: 361-385, 2009.
16. Pritchard CC, Cheng HH and Tewari M: MicroRNA profiling: Approaches and considerations. Nat Rev Genet 13(5): 358-369, 2012.
17. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F and Croce CM: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99(24): 15524-15529, 2002. (Pubitemid 35403967)
18. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL and Coukos G: MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103(24): 9136-9141, 2006. (Pubitemid 43902545)
19. Tagawa H and Seto M: A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19(11): 2013-2016, 2005. (Pubitemid 41554018)
20. Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC, Fredrickson T, Landgraf P, Ramachandra S, Huppi K, Toro JR, Zenger VE, Metcalf RA and Marti GE: Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109(12): 5079-5086, 2007. (Pubitemid 46890521)
21. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M and Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16): 7065-7070, 2005. (Pubitemid 41161233)
22. Iorio MV and Croce CM: MicroRNA involvement in human cancer. Carcinogenesis 33(6): 1126-1133, 2012.
23. Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G and Kerin MJ: MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res 11(3): R27, 2009.
24. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio M V, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M and Croce CM: A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353(17): 1793-1801, 2005. (Pubitemid 41549891)
25. Schee K, Boye K, Abrahamsen TW, Fodstad O and Flatmark K: Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer 12: 505, 2012.
26. Chen LH, Tsai KL, Chen YW, Yu CC, Chang KW, Chiou SH, Ku HH, Chu PY, Tseng LM, Huang PI and Lo WL: MicroRNA as a novel modulator in head and neck squamous Carcinoma. J Oncol 2010: 1-15, article ID: 135632, 2010.
27. Boldrup L, Coates PJ, Wahlgren M, Laurell G, Nylander K: Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins. J Carcinog 11(19): 1-7, 2012.
28. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, Pintilie M, Jurisica I, Perez-Ordonez B, Gilbert R, Gullane P, Irish J and Kamel-Reid S: Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 18: 4818-4829, 2009.
29. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, Gullane P, Cummings B and Liu FF: Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas, Clin Cancer Res 16: 1129-1139, 2010.
30. Avissar M, Christensen BC, Kelsey KT and Marsit CJ: MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855, 2009.
31. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E and Wong DT: Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15: 5473-5477, 2009.
32. Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA: Human papillomavirus alters microRNA profiles in squamous cell carcinoma of the head and neck (SCCHN) cell lines. Head Neck 33(4): 504-512, 2011.
33. http://www.mirbase.org/ last accessed 10.01.2013.
34. Babu JM, Prathibha R, Jijith VS, Hariharan R and Radhakrishna Pillai M: A miR-centric view of head and neck cancers. Biochim Biophys Acta 1816: 67-72, 2011.
35. http://www.tarmir.rgcb.res.in/henecan/ last accessed: 10.01.2013.
36. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS and Cheng JQ: MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28: 6773-6784, 2010.
37. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CCA and Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci 103(7): 2257-2261, 2006. (Pubitemid 43271657)
38. Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo YY: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359, 2008. (Pubitemid 351333899)
39. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH and Li Y: MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 genemiR-21 targets PDCD4. Oncogene 27: 4373-4379, 2008. (Pubitemid 352010003)
40. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P and Song E: miR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15(12): 3998-4008, 2012.
41. Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M, Sukhai MA, Perez-Ordonez B, Grénman R, Gilbert RW, Gullane PJ, Irish JC and Kamel-Reid S: Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 9: 238, 2010.
42. Warner GC, Reis PP, Jurisica I, Sultan M, Arora S, Macmillan C, Makitie AA, Grenman R, Reid N, Sukhai M, Freeman J, Gullane P, Irish J and Kamel-Reid S: Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 110: 857-868, 2004. (Pubitemid 38758512)
43. Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G and Croce CM: miR-221 and 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 down-regulation. Cancer Cell 16(6): 498-509, 2009.
44. Visone R, Russo L, Pallante P, De Martino I, Ferraro, Leone V, Borbone, Petrocca F, Adler H, Croce CM and Fusco A: MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27 KIP1 protein levels and cell cycle. Endocr Relat Cancer 14: 791-798, 2007. (Pubitemid 350074067)
45. Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar, Ang KK and Story MD: miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissues. Head Neck 31: 642-654, 2009.
46. Kozomara A and Griffiths-Jones S: miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: 152-157, 2011.
47. Li Y, VandenBoom TG II, Wang Z, Kong D, Ali S, Philip AP and Sarkar FH: miR-146a Suppresses invasion of pancreatic cancer cells. Cancer Res 70(4): 1486-1495, 2010.
48. Wong TS, Liu XB, Chung-WHA, Po-Wing YA, Wai-Man NR and Ignace WW: Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 123(2): 251-257, 2008.
49. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP and Wei WI: Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14(9): 2588-2592, 2008.
50. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D and Califano JA: MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123(12): 2791-2797, 2008.